Mather Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Mather Group's GILD Position: Q2 2026 in Review
Mather Group reduced its Gilead Sciences (GILD) stake by 1.6% in Q2 2026, selling an estimated $71.3K and leaving 33,347 shares worth $4.21M. The position accounts for 0.04% of the portfolio, ranked #176.
Mather Group first reported a position in GILD in Q3 2022 and has held it in 16 quarters since. The position peaked at $4.72M in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Mather Group held 33,347 shares of Gilead Sciences worth $4.21M as of Q2 2026.
- Mather Group sold 541 Gilead Sciences shares in Q2 2026, an estimated $71.3K.
- Gilead Sciences made up 0.04% of Mather Group's portfolio in Q2 2026, its #176 holding.
- Mather Group first reported a position in Gilead Sciences in Q3 2022 and has held it in 16 quarters since.
- Mather Group's Gilead Sciences position peaked at $4.72M in Q1 2026.
- 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.